71 related articles for article (PubMed ID: 38588015)
1. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.
Massari F; Santoni M; Ciccarese C; Santini D; Alfieri S; Martignoni G; Brunelli M; Piva F; Berardi R; Montironi R; Porta C; Cascinu S; Tortora G
Cancer Treat Rev; 2015 Feb; 41(2):114-21. PubMed ID: 25586601
[TBL] [Abstract][Full Text] [Related]
2. GHITM regulates malignant phenotype and sensitivity to PD-1 blockade of renal cancer cells via Notch signalling.
Huang S; Liu J; Hu J; Hou Y; Hu M; Zhang B; Luo H; Fu S; Chen Y; Liu X; Chen Z; Wang L
J Cell Mol Med; 2024 Apr; 28(8):e18290. PubMed ID: 38588015
[TBL] [Abstract][Full Text] [Related]
3. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract][Full Text] [Related]
4. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway.
Liu Y; Qu HC
J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647
[TBL] [Abstract][Full Text] [Related]
5. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
6. Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Zheng Z; Li X; Nie K; Wang X; Liang W; Yang F; Zheng K; Zheng Y
Front Immunol; 2023; 14():1038651. PubMed ID: 37033923
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression.
Wu L; Zhou Z; Yu Y; Cheng C; Zhou S; Yan Y; Yu B; Zhang Y; Liu Z
Cell Death Dis; 2024 Feb; 15(2):137. PubMed ID: 38351178
[TBL] [Abstract][Full Text] [Related]
9. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
11. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract][Full Text] [Related]
12. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mitochondrial proteostasis by the proton gradient.
Patron M; Tarasenko D; Nolte H; Kroczek L; Ghosh M; Ohba Y; Lasarzewski Y; Ahmadi ZA; Cabrera-Orefice A; Eyiama A; Kellermann T; Rugarli EI; Brandt U; Meinecke M; Langer T
EMBO J; 2022 Aug; 41(16):e110476. PubMed ID: 35912435
[TBL] [Abstract][Full Text] [Related]
14. Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma.
Ingels A; Campi R; Capitanio U; Amparore D; Bertolo R; Carbonara U; Erdem S; Kara Ö; Klatte T; Kriegmair MC; Marchioni M; Mir MC; Ouzaïd I; Pavan N; Pecoraro A; Roussel E; de la Taille A
Nat Rev Urol; 2022 Jul; 19(7):391-418. PubMed ID: 35546184
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]